Venetoclax in combination with hypomethylating agents in newly diagnosed and relapsed <i>CBF</i>β<i>::MYH11+</i> acute myeloid leukemia

Venetoclax in combination with hypomethylating agents in newly diagnosed and relapsed <i>CBF</i>β<i>::MYH11+</i> acute myeloid leukemia

Not available.

Saved in:

Bibliographic Details
Main Authors:	Ziyu Feng, Xiaohui Hu, Weiyang Li, Ting Xu, Yang Xu, Shengli Xue, Huiying Qiu, Xiaowen Tang, Yue Han, Suning Chen, Aining Sun, Yanming Zhang, Depei Wu, Ying Wang
Format:	Article
Language:	English
Published:	Ferrata Storti Foundation 2025-02-01
Series:	Haematologica
Online Access:	https://haematologica.org/article/view/11951
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Prospective clinical trials of venetoclax and hypomethylating agents for relapsed BPDCN
by: Naveen Pemmaraju, et al.
Published: (2025-05-01)

Impact of KIT mutation on efficacy of venetoclax and hypomethylating agents in newly diagnosed acute myeloid leukemia
by: Wenxiu Shu, et al.
Published: (2025-05-01)

Identification of the CBF Gene Family in Wheat and <i>TaCBF14B</i> Could Enhance the Drought Tolerance of <i>Arabidopsis thaliana</i>
by: Zubaidai Abudukerimu, et al.
Published: (2025-05-01)

Efficacy of the combination of venetoclax and hypomethylating agents in the treatment of patients with primary, relapsed and/or refractory acute myeloid leukemia
by: E. V. Usikova, et al.
Published: (2023-01-01)

Venetoclax and azacitidine for molecular relapse after intensive chemotherapy in NPM1 or CBF AML: a FILO study
by: Jules Higué, et al.
Published: (2025-08-01)

Genome-Wide Identification and Expression Divergence of <i>CBF</i> Family in <i>Actinidia arguta</i> and Functional Analysis of <i>AaCBF4</i> Under Cold Stress
by: Sumei Li, et al.
Published: (2025-02-01)

VENETOCLAX-BASED VERSUS 7+3 INDUCTION THERAPY IN FIT YOUNGER ADULTS WITH NEWLY DIAGNOSED NON-CBF AML
by: Dmitrii Zhogolev, et al.
Published: (2025-07-01)

Molecular predictors of response and survival in patients with relapsed/refractory acute myeloid leukemia following venetoclax plus hypomethylating agent therapy
by: Isla M. Johnson, et al.
Published: (2025-02-01)

Reduced venetoclax exposure to 7 days vs standard exposure with hypomethylating agents in newly diagnosed AML patients
by: Christophe Willekens, et al.
Published: (2025-04-01)

Venetoclax and hypomethylating agents versus induction chemotherapy for newly diagnosed acute myeloid leukemia patients: a systematic review and meta-analysis
by: Yun Liu, et al.
Published: (2025-05-01)

Better Response and Prognosis of Venetoclax Plus Hypomethylating Agents Over Intensive Chemotherapy in Young Adults With Newly Diagnosed ASXL1‐Mutated Acute Myeloid Leukemia
by: Yiming Cai, et al.
Published: (2025-07-01)

Outcomes With Venetoclax 50 mg, Hypomethylating Agents, and Voriconazole or Posaconazole in Acute Myeloid Leukemia
by: Kendall Diebold, et al.
Published: (2025-06-01)

Impact of monocytic differentiation on acute myeloid leukemia patients treated with venetoclax and hypomethylating agents
by: Dian Jin, et al.
Published: (2024-07-01)

Venetoclax Combined with Hypomethylating Agents for Treatment-Naïve B/Myeloid Mixed Phenotype Acute Leukemia
by: Di Wu, et al.
Published: (2021-01-01)

Real-life outcome after failure to venetoclax and hypomethylating-based therapy for acute myeloid leukemia
by: Carlos Jiménez-Vicente, et al.
Published: (2025-01-01)

Meta-analysis on the effectiveness and safety of venetoclax-based combination therapy with hypomethylation in acute myeloid leukemia
by: Yi Wang, et al.
Published: (2025-04-01)

The efficacy of the combination of venetoclax and hypomethylating agents versus HAG agents in patients with acute myeloid leukemia: a retrospective study
by: Fei Xin, et al.
Published: (2024-12-01)

Older Jehovah’s Witnesses with Acute Myeloid Leukemia: Hypomethylating Agents and Venetoclax as a Transfusion-Sparing Approach
by: Aditi Sharma, et al.
Published: (2025-06-01)

Exposure-response analyses of venetoclax combined with hypomethylating agents in myelodysplastic syndromes: a retrospective study
by: Ji-Xin Tian, et al.
Published: (2025-07-01)

<i>Saussurea involucrata CML6</i> Enhances Freezing Tolerance by Activating Antioxidant Defense and the CBF-COR Pathway in Plants
by: Mengjuan Hou, et al.
Published: (2025-08-01)

Clinical characteristics and therapeutic determinants of <i>RUNX1::RUNX1T1</i> differ from those of <i>CBFB::MYH11</i> acute myeloid leukemia
by: Miao Yang, et al.
Published: (2025-04-01)

Hypomethylating agent versus venetoclax combination: an electronic health records-based target trial emulation among Asian elderly patients with newly diagnosed acute myeloid leukaemia in Hong Kong
by: Qiwen Fang, et al.
Published: (2025-07-01)

Morphology and Phylogeny Reveal New Species and Records of <i>Diplodia</i>, <i>Dothiorella</i>, and <i>Phaeobotryon</i> Associated with Tree Cankers in Xizang, China
by: Jia Zhou, et al.
Published: (2025-04-01)

<i>LINE-1</i> hypomethylation and <i>HIST1H4F</i> hypermethylation as oncomarkers in liquid biopsy of colorectal cancer
by: V. N. Kondratova, et al.
Published: (2024-06-01)

DNA Hypomethylation Underlies Epigenetic Swapping between <i>AGO1</i> and <i>AGO1-V2</i> Isoforms in Tumors
by: Jean S. Fain, et al.
Published: (2024-06-01)

Genetic and Epigenetic Aberrations of <i>SOX7</i> in Newly Diagnosed and Relapsed Multiple Myeloma as Well as Related Neoplasms
by: Can Küçük, et al.
Published: (2025-04-01)

Blocking platelet glycoprotein V cleavage reduces bleeding in mouse models of <i>MYH9</i>-related disease
by: Patricia Öftering, et al.
Published: (2025-06-01)

New Variant of <i>MYH7</i> Gene Nucleotide Sequence in Familial Non-Compaction Cardiomyopathy with Benign Course
by: R. P. Myasnikov, et al.
Published: (2020-07-01)

Familial hypertrophic cardiomyopathy with midventricular obstruction associated with <i>MYH7, FHOD3</i> and <i>BAG3</i> gene variants: a case report
by: S. E. Andreeva, et al.
Published: (2024-12-01)

Hypomethylating agents plus venetoclax for high-risk MDS and CMML as bridge therapy to transplant: a GESMD study
by: Ines Zugasti, et al.
Published: (2025-04-01)

CbCBF2 Integrates JA and BR Signaling to Enhance Oleanolic Acid Biosynthesis in <i>Conyza blinii</i> H. Lév Under Cold Stress
by: Ming Yang, et al.
Published: (2025-04-01)

Clinical and genetic characteristics of type 7 distal arthrogryposis caused by a pathogenic variant in the <i>MYH8</i> gene
by: I. V. Sharkova, et al.
Published: (2023-10-01)

Single-center experience of venetoclax combined with azacitidine in young patients with newly diagnosed acute myeloid leukemia
by: Xuezhu Xu, et al.
Published: (2025-01-01)

Selinexor in combination with venetoclax and decitabine in patients with refractory myelodysplastic syndrome previously exposed to hypomethylating agents: three case reports
by: Yunshuo Xiao, et al.
Published: (2024-12-01)

Reduced duration and dosage of venetoclax is efficient in newly diagnosed patients with acute myeloid leukemia
by: Jingying Cui, et al.
Published: (2024-12-01)

Significant prognostic improvement in elderly patients with acute myeloid leukemia treated with hypomethylating agents and venetoclax: outcomes from a retrospective real-world analysis
by: Yi Chen, et al.
Published: (2025-12-01)

Prognostic value of measurable residual disease (MRD) for venetoclax in combination with hypomethylating agents in patients diagnosed with acute myeloid leukemia: validation of the ELN-2021 MRD recommendations
by: Carlos Jimenez-Vicente, et al.
Published: (2025-05-01)

Reply to <i>Before scoliosis can be attributed to the variant c.326G>A in MYH3, its pathogenicity must be proven</i>
by: Maria Chiara Maccarone, et al.
Published: (2025-06-01)

The oral CDK9 inhibitor voruciclib combined with venetoclax for patients with relapsed/refractory acute myeloid leukemia
by: Yesid Alvarado-Valero, et al.
Published: (2025-08-01)

REAL WORLD OUTCOMES OF HYPOMETHYLATING AGENTS AND VENETOCLAX COMBINATION THERAPY IN ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME- SINGLE CENTER EXPERIENCE FROM A RESOURCE LIMITED COUNTRY
by: Maryam Khan
Published: (2025-07-01)